vTv Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin, being investigated for the treatment of type 1 diabetes (T1D). Its product pipeline includes TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
/ 
Others were interested in
Frequently asked questions
To buy vTv Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for vTv Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for vTv Therapeutics Inc. is VTVT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
vTv Therapeutics Inc. has its primary listing on NASDAQ. You can trade vTv Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, vTv Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include vTv Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like vTv Therapeutics Inc..